OFFICE OF RESEARCH AND SPONSORED PROGRAMS Monthly Summary of Grants and Contract Activity May 2014 Corporate Federal Federal Flow-Down Foundation/Other Non-Profit 1 28 23 14 4 3,916,511 9,855,291 1,215,649 180,520 69 $ 15,167,971 May 2014 Medical University of South Carolina Printed: Jun 12, 2014 PROPOSALS Submitted since July 2013 DEPARTMENT College/Unit and Department Administration Academic Affairs/Provost Assoc. Provost for Research Information Services Library Science and Informatics Physical Plant Risk Management SC AHEC VP for Finance and Administration College of Dental Medicine Oral Health Sciences Pediatric Dentistry and Orthodontics Stomatology College of Graduate Studies Graduate Studies College of Health Professions Health Professions Health Sciences and Research Health Studies Healthcare Leadership & Management College of Medicine Anesthesia and Perioperative Medicine Biochemistry and Molecular Biology Cell and Molecular Pharmacology Comparative Medicine Deans Office - COM Dermatology Family Medicine Medicine Microbiology and Immunology Neurology Reseach Neurosciences Neurosurgery Research Obstetrics and Gynecology Ophthalmology Orthopaedic Surgery Otolaryngology Pathology and Laboratory Medicine Pediatrics Psychiatry and Behavioral Sciences Public Health Sciences Radiation Oncology Radiology Regenerative Medicine and Cell Biology Surgery Urology College of Nursing Nursing Current Month YTD COLLEGE/UNIT Current Total Month YTD 0 0 0 0 0 0 0 1 2 18 1 18 1 1 3 1 130,687 991,419 920,000 2,171,673 250 3,000,000 2,087,914 242 4 0 0 22 2 3 4,513,034 34,850 114,917 1 1 42,361 1 0 0 0 11 28 1 2 1,620,022 9,392,504 1,913,063 279,450 0 6 10 1 0 0 1 35 6 5 9 4 2 4 0 6 6 15 21 8 2 4 3 3 2 1 38 43 7 6 1 7 323 97 31 160 11 17 32 10 35 59 128 195 63 7 48 58 60 14 368,750 10,241,755 12,065,986 716,797 6,852,142 210,597 2,496,456 62,916,573 19,321,602 4,623,293 29,747,873 449,315 2,834,769 7,469,771 4,215,535 3,985,162 10,412,122 14,436,457 46,186,212 13,351,563 1,486,605 5,217,023 11,191,511 10,133,423 1,946,311 6 2 45 Total 1 45 9,302,185 4 27 4,662,801 1 1 42,361 1 42 13,205,039 153 1451 282,877,603 6 45 8,555,026 8,555,026 May 2014 Medical University of South Carolina Printed: Jun 12, 2014 PROPOSALS Submitted since July 2013 DEPARTMENT College/Unit and Department College of Pharmacy Drug Discovery & Biomedical Sciences Pharmacy and Clinical Sciences Current Month YTD COLLEGE/UNIT Current Total Month YTD 3 3 37 7,648,715 0 2 123,175 Total Proposals Submitted: 3 169 39 Total 7,771,890 1,650 326,416,905 May 2014 Medical University of South Carolina Printed: Jun 12, 2014 AWARD ACTIVITY LISTED BY FUNDING AGENCY # Awards Direct Costs Total Costs 1 1 1 1 1 1 1 1 1 1 1 1 2 1 1 2 1 1 1 1 1 1 1 1 2 28 1,084 116,812 40,134 72,577 37,507 445,902 94,858 29,615 283,315 161,403 61,695 6,438 137,735 501,885 25,000 315,881 106,996 48,191 102,587 163,031 28,000 175,938 55,931 462 41,792 3,054,769 1,355 150,956 60,000 93,000 56,073 578,473 118,572 38,500 340,410 208,474 76,025 8,370 176,955 651,250 25,000 406,760 138,795 62,348 132,388 211,040 28,000 227,820 71,960 577 53,410 3,916,511 1 1 7 1 0 1 1 5 1 2 3 23 86,760 2,364,857 821,925 125,000 41,487 50,000 220,797 1,535,522 745,806 694,286 783,018 7,469,458 125,748 2,888,812 1,202,079 186,875 61,194 74,750 299,574 2,098,459 1,097,689 893,493 926,618 9,855,291 1 1 1 1 2 1 1 1 1 1 22,073 34,638 95,557 230,764 1,234 5,200 80,105 5,119 8,200 102,330 32,557 51,783 142,858 344,992 1,580 5,200 90,828 7,551 12,259 128,233 Corporate AVEO Pharmaceuticals, Inc. Astellas Pharma US, Inc. Astrazeneca Avedro Inc. Berg, LLC Biosense Webster, Inc. Celator Pharmaceuticals, Inc. Childrens Hosp. of Philadelphia Cook, Inc. Duke Univ. Genentech, Inc. INC Research, Inc. INNO Clinical Outcomes, LLC InfraReDx, Inc. Multiple Sponsors Novartis Corp. PRA International Portola Pharmaceuticals, Inc. Quintiles Pacific, Inc. SCRI Development Innovations, LLC Siemens Medical Solutions USA Taris Biomedical, Inc. The Medicines Co. Univ. of California, Los Angeles W.L. Gore and Associates, Inc. Federal DOD NIH/NCATS NIH/NCI NIH/NIA NIH/NIAAA NIH/NIAMS NIH/NICHD NIH/NIDA NIH/NIGMS NIH/NIMH NIH/NINDS Federal Flow-Down Allegheny-Singer Research Inst. Beth Israel Deaconess Med. Ctr. Clemson Univ. Mt. Sinai School of Medicine New England Research Institutes SC Sea Grant Consortium SCUREF Temple University Univ. of Nebraska Univ. of Pennsylvania 4 May 2014 Medical University of South Carolina Printed: Jun 12, 2014 AWARD ACTIVITY LISTED BY FUNDING AGENCY # Awards Direct Costs Total Costs 1 2 14 11,217 258,483 854,920 16,545 381,263 1,215,649 1 1 1 1 4 5,020 100,000 75,000 500 180,520 5,020 100,000 75,000 500 180,520 69 11,559,667 $15,167,971 Federal Flow-Down Univ. of Rochester Univ. of South Carolina Foundation/Other Non-Profit American Academy of Otolaryngic Allergy Lupus Research Institute Melanoma Research Alliance Sigma Xi Grand Totals: 5 May 2014 Medical University of South Carolina Printed: Jun 12, 2014 AWARD ACTIVITY LISTED BY COLLEGE AND DEPARTMENT # Awards Direct Costs Total Costs 1 1 25,000 $ 25,000 25,000 $25,000 1 1 95,557 $ 95,557 142,858 $142,858 1 1 18 6 4 7 2 1 2 5 8 3 4 1 2 2 67 69 201,275 42,676 2,431,185 599,602 754,711 1,795,300 5,700 72,577 225,817 76,704 3,522,980 285,883 125,723 745,806 270,237 282,934 $ 11,439,110 $ 11,559,667 300,906 42,676 3,137,821 814,019 872,159 2,575,302 5,700 93,000 304,594 108,408 4,339,257 425,622 153,370 1,097,689 362,975 366,615 $15,000,113 $ 15,167,971 Administration Library Science & Informatics College of Dental Medicine Oral Health Sciences College of Medicine Biochemistry & Molecular Biology Cell & Molecular Pharmacology Medicine Microbiology & Immunology Neurology Neurosciences Obstetrics & Gynecology Ophthalmology Otolaryngology Pediatrics Psychiatry & Behavioral Sciences Public Health Sciences Radiology Regenerative Medicine & Cell Biology Surgery Urology Grand Totals: 6 May 2014 Medical University of South Carolina Printed: Jun 12, 2014 Administration Library Science & Informatics Rivers, D Corp. Support - National Conference on Health Disparities Multiple Sponsors 02/01/2007 - 12/31/2016 02/01/2007 - 12/31/2016 Conference (016935) $25,000 0 $25,000 $95,557 47,301 $142,858 $201,275 99,631 $300,906 Role of EZH2 in Extracellular Hsp90 Mediated Prostate Cancer Tumorigenesis NIH/NCI 05/01/2014 - 04/30/2015 05/01/2013 - 04/30/2016 5F31CA177015-02 (017643) $42,676 0 $42,676 A Phase Ib Open Label Study of the Safety and Tolerability of ME-344 Given in Combination with Topotecan (Hycamtin) in Patients with Solid Tumors SCRI Development Innovations, LLC 04/30/2014 - 04/29/2018 04/30/2014 - 04/29/2018 ME-344-002 (018314) $163,031 48,009 $211,040 reMARQable: nMARQ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation - IDE 120289 Biosense Webster, Inc. 05/27/2014 - 12/31/2018 05/27/2014 - 12/31/2018 reMARQable (018330) $445,902 132,571 $578,473 A Rollover Protocol to Allow Continued Access to Tivozanib Hydrochloride (AV 951) for Subjects Enrolled in Other Tivozanib Hydrochloride Protocols AVEO Pharmaceuticals, Inc. 12/20/2012 - 12/19/2019 12/20/2012 - 12/19/2019 AV-951-09-901 (017435) $1,084 271 $1,355 12/05/2013 - 10/31/2018 12/05/2013 - 10/31/2018 $37,507 18,566 $56,073 Multicenter, Randomized, Active-Controlled Efficacy and Safety Study Comparing Extended Duration Betrixaban With Standard of Care Enoxaparin for the Prevention of Venous Thromboembolism in Acute Medic Portola Pharmaceuticals, Inc. 03/28/2014 - 09/01/2015 03/28/2014 - 09/01/2015 11-019 (018291) $48,191 14,157 $62,348 Identification of PIM Kinase Substrates in Sensitive DLBCL, Myeloma and Prostate Cancer Cells by Mass Spectrometry Astrazeneca 04/28/2014 - 04/27/2015 04/28/2014 - 04/27/2015 (018309) $40,134 19,866 $60,000 College of Dental Medicine Oral Health Sciences Kirkwood, K Integrating Biomechanics and Cell Biology to Understand TMJ Pathology Clemson Univ. 03/01/2014 - 02/28/2015 03/06/2012 - 02/28/2015 R01DE021134/1602-209-2008855 (016962) College of Medicine Biochemistry & Molecular Biology Heise, T Screen for Inhibitors of La-Dependent IRES-Mediated Translation in Cancer Cells NIH/NCI 05/01/2014 - 04/30/2015 05/03/2013 - 04/30/2016 5R01CA172567-02 (017739) Cell & Molecular Pharmacology Nolan, K Medicine Britten, C Cuoco, F Drabkin, H Gilkeson, G Greenberg, C Kraft, A New Target Identification in Lupus Berg, LLC (018306) 7 May 2014 Medical University of South Carolina Printed: Jun 12, 2014 College of Medicine Medicine Mims, A Oates, J Oates, J Powers, E Ramos, P Shirai, K Shirai, K Stuart, R Stuart, R Tanner, N Van Bakel, A A Phase 2 Open-Label Study of the Efficacy of ABT-199 (GDC-0199) in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia Harboring the 17p Deletion INC Research, Inc. 05/20/2014 - 07/31/2014 05/20/2014 - 07/31/2014 M13-982 (018329) $6,438 1,932 $8,370 A Phase II, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multi-dose, 24-week study to Evaluate the Efficacy and Safety of Atacicept in Subjects with SLE Quintiles Pacific, Inc. 05/07/2014 - 05/06/2017 05/07/2014 - 05/06/2017 EMR700461-023 (018322) $102,587 29,801 $132,388 Identification of Dysregulated Pathways in SLE Genentech, Inc. (018297) 03/28/2014 - 03/27/2016 03/28/2014 - 03/27/2016 $61,695 14,330 $76,025 Lipid Rich Plaque (LRP) Outcomes Study InfraReDx, Inc. LRP Pcl# CL0116 (018317) 04/29/2014 - 12/31/2018 04/29/2014 - 12/31/2018 $501,885 149,365 $651,250 DNA Methylation Biomarkers of Scleroderma-Associated Interstitial Lung Disease NIH/NIAMS 05/01/2014 - 04/30/2015 05/01/2014 - 04/30/2017 1R03AR065801-01 (018294) $50,000 24,750 $74,750 A Phase Ib Dose Escalation/Randomized Phase II, Multicenter, Open-Label Study Of BYL719 In Combination With Cetuximab In Patients With Recurrent Or Metastatic Head and Neck Squamous Cell Carcinoma Novartis Corp. 05/16/2014 - 05/15/2016 05/16/2014 - 05/15/2016 BYL719X2104 (018319) $181,777 53,183 $234,960 An Open-Label, Multi-center, Expanded Treatment Protocol (ETP) Of Oral LDK378 In Adult Patients With Non-Small Cell Lung Cancer (NSCLC) Characterized By ALK(+) Rearrangements In Patients Previously Novartis Corp. 02/11/2014 - 06/30/2016 02/11/2014 - 06/30/2016 CLDK378A2402 (018298) $134,104 37,696 $171,800 A Phase 1/2 Open-Label, Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP2215 in Patients with Relapsed or Refractory Acute Myeloid Leukemia Astellas Pharma US, Inc. 04/07/2014 - 04/06/2017 04/07/2014 - 04/06/2017 2215-CL-0101 (018302) $116,812 34,144 $150,956 Phase III, Multi-Center, Randomized Trial of CPS-351 Liposome Injection vs Cytarabine and Daunorubicin in Patients 60-75 Years of Age Celator Pharmaceuticals, Inc. 12/31/2012 - 12/30/2017 12/31/2012 - 12/30/2017 CLTR0310-301 (017414) $94,858 23,714 $118,572 A Multi-Center Trial Comparing Standard 22-Gauge and 22-Gauge Procor Needles for Endobronchial Ultrasound Cook, Inc. 04/29/2014 - 04/28/2016 04/29/2014 - 04/28/2016 Cook Medical (018295) $283,315 57,095 $340,410 Effect of Everolimus Immunotherapy on Anti-HLA Antibody Mediated Activation of Endothelial Cells. A Retrospective Mechanistic Substudy of the Novartis Sponsored Trial Univ. of California, Los Angeles 10/21/2011 - 12/31/2014 10/21/2011 - 12/31/2014 1625-P-PC853 RAD Substudy (017633) $462 115 $577 8 May 2014 Medical University of South Carolina Printed: Jun 12, 2014 College of Medicine Medicine Whelan, T Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry (IPF_PRO) Duke Univ. 05/01/2014 - 03/31/2019 05/01/2014 - 03/31/2019 IPF_PRO (018296) $161,403 47,071 $208,474 Costimulatory Mechanisms of Antitumor Th17 Cell Immunity NIH/NCI 05/01/2014 - 04/30/2015 07/01/2013 - 04/30/2018 5R01CA175061-02 (017785) $201,275 99,632 $300,907 Management of the Nuclear Advisory Committee (NEAC) SCUREF 03/03/2011 - 02/09/2016 03/03/2011 - 02/09/2016 DE-NE0000393/DENE005 (016374) $80,105 10,723 $90,828 Chemotherapy Necessitates Increased Immune Control of Chronic HHVs: A Cause of Persistent Inflammation Enabling Protracted Fatigue in Breast Cancer Survivors DOD 05/01/2014 - 04/30/2015 09/15/2011 - 04/30/2015 W81XWH-11-1-0704-P00001 (016957) $86,760 38,988 $125,748 Antigen Specific Suppression of Autoimmunity in Lupus Lupus Research Institute 08/15/2011 - 02/28/2014 08/15/2011 - 02/28/2014 (017596) $100,000 0 $100,000 Alloreactive Regulatory T Cells Control GVHD and Maintain GVL Effect NIH/NCI 07/01/2013 - 06/30/2014 07/01/2013 - 06/30/2016 7R01CA118116-06 (017870) $80,806 39,999 $120,805 Th1/Th17 Cell Differentiation in GVHD and GVL NIH/NCI 7R01CA143812-04 (017744) 06/14/2013 - 10/31/2014 06/01/2010 - 10/31/2014 $50,656 25,075 $75,731 Tailored Hospital-Based Risk Reduction to Impede Vascular Events after Stroke NIH/NINDS 05/01/2014 - 04/30/2015 09/01/2012 - 04/30/2017 5U01NS079179-04 (017411) $444,657 64,442 $509,099 An Open-Label, Long-Gterm Safety Study of SD-809 (Dutetrabenazine) For the Treatment of Moderate to Severe Tardive Dyskinesia - Protocol Number:SD-809-C-20 INNO Clinical Outcomes, LLC 05/14/2014 - 05/31/2016 05/14/2014 - 05/31/2016 SD-809-C-18 (018312) $137,735 39,220 $176,955 Characterization of Intracranial Atherosclerotic Stenosis Using HR MRI NIH/NINDS 05/01/2014 - 04/30/2015 05/01/2011 - 04/30/2016 5K23NS069668-04 (016700) $172,319 13,786 $186,105 Cortical Stimulation to Enhance Motor Recovery Following Traumatic Brain Injury NIH/NINDS 05/01/2014 - 04/30/2015 05/01/2011 - 04/30/2016 5R01NS065866-05 (016421) $166,042 65,372 $231,414 Role of Locus Coeruleus in Response Inhibition NIH/NIMH 5R01MH092868-04 (016208) $225,000 106,875 $331,875 Microbiology & Immunology Paulos, C Schmidt, M Thaxton, J Vasu, C Yu, X Yu, X Neurology Ovbiagele, B Revuelta, G Turan, T Neurosciences Adkins, D Aston-Jones, G 9 05/01/2014 - 04/30/2015 07/22/2011 - 04/30/2016 May 2014 Medical University of South Carolina Printed: Jun 12, 2014 College of Medicine Neurosciences Gipson, C Kalivas, P Mulholland, P Reichel, C Sambamurti, K Spencer, S Contributions of Glial Glutamate Transport and NMDA Receptors in Nicotine Relapse NIH/NIDA 05/15/2014 - 04/30/2015 05/15/2014 - 04/30/2016 1K99DA036569-01 (018305) $121,346 9,708 $131,054 Neurobiology of Addiction Center NIH/NIDA 5P50DA015369-12 (016624) 05/01/2014 - 04/30/2015 07/01/2002 - 04/30/2018 $872,665 425,156 $1,297,821 Stress and Ethanol Dependence: SK Channels and Glutamate NIH/NIAAA 02/01/2014 - 01/31/2015 02/10/2012 - 01/31/2017 5U01AA020930-03 (016329) $8,717 4,141 $12,858 Corticostriatal Neuroplasticity and Cognition in Methamphetamine Addiction NIH/NIDA 06/01/2014 - 05/31/2015 09/15/2012 - 05/31/2017 5R01DA033049-03 (017154) $225,000 106,875 $331,875 Understanding the Neuroprotective Activities of Posiphen NIH/NIA 05/01/2014 - 04/30/2015 07/15/2013 - 04/30/2015 5R21AG046200-02 (017826) $125,000 61,875 $186,875 Role of Alpha2delta-1 in Cocaine Relapse and Gabapentin Mechanisms of Action NIH/NIDA 05/01/2014 - 04/30/2015 05/01/2014 - 04/30/2016 1F32DA037722-01 (018263) $51,530 0 $51,530 Lipidomic Analysis of Eicosanoid Signaling in Inflammation and Endometrial Cancer Sigma Xi 03/01/2014 - 02/28/2015 03/01/2014 - 02/28/2015 (018300) $500 0 $500 Summer Undergraduate Research Program in Oceans and Human Health SC Sea Grant Consortium 05/26/2014 - 09/01/2014 05/29/2012 - 09/01/2014 NA10OAR4170073/M11Z (017065) $5,200 0 $5,200 A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety & Efficacy of the KXL System w/ VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes w/ Kerataconus Avedro Inc. 05/15/2014 - 05/14/2019 05/15/2014 - 05/14/2019 KXL-001 (018326) $72,577 20,423 $93,000 05/01/2014 - 04/30/2015 05/01/2012 - 04/30/2017 $220,797 78,777 $299,574 Relationship Between Sinonasal Mucosal Remodeling and Disease Severity in Atopic and Non-Atopic CRS American Academy of Otolaryngic Allergy 05/01/2014 - 07/31/2014 05/01/2014 - 07/31/2014 (018282) $5,020 0 $5,020 NERI/NIH Site Service Agreements New England Research Institutes U01HL68270 (017600) $1,234 346 $1,580 Obstetrics & Gynecology Cantu, T Guillette, L Ophthalmology Waring, G Otolaryngology Eckert, M Oconnell, B Methods for Retrospective Multi-Site Research NIH/NICHD 5R01HD069374-03 (016634) Pediatrics Atz, A 03/04/2014 - 06/30/2016 01/28/2013 - 06/30/2016 10 May 2014 Medical University of South Carolina Printed: Jun 12, 2014 College of Medicine Pediatrics Kraveka, J Lee, K Ryan, R A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine in the Very High Risk Stratum Childrens Hosp. of Philadelphia 05/28/2014 - 05/30/2016 05/28/2014 - 05/30/2016 AALL1131 (018332) $29,615 8,885 $38,500 Elucidating the Phosphatase-Independent Roles of PTPN11 in the Heart Beth Israel Deaconess Med. Ctr. 04/01/2014 - 03/31/2015 06/01/2013 - 03/31/2017 R01HL114775/01026527 (017994) $34,638 17,145 $51,783 Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies Univ. of Rochester 05/01/2014 - 04/30/2015 07/01/2011 - 04/30/2015 U01HL101813/416385 (016775) $11,217 5,328 $16,545 05/01/2014 - 04/30/2015 05/26/2006 - 04/30/2016 $132,490 10,599 $143,090 Ethanol Dependence and Stress Effects on Ethanol Drinking: Role of CRF NIH/NIAAA 02/01/2014 - 01/31/2015 03/01/2003 - 01/31/2017 5U01AA014095-12 (016391) $13,930 6,617 $20,547 South Carolina Clinical and Translational Research Institute NIH/NCATS 05/15/2014 - 03/31/2015 07/14/2009 - 03/31/2015 3UL1TR000062-05S1 (016836) $2,364,857 523,955 $2,888,812 05/01/2014 - 04/30/2015 05/26/2006 - 04/30/2016 $132,490 10,599 $143,090 The Effect of Point-of-Sale Tobacco Marketing on Smoking Cessation Among Adults Univ. of Nebraska 03/01/2014 - 02/28/2015 03/07/2013 - 02/28/2015 R01CA166156/34-5450-2003-001 (017872) $8,200 4,059 $12,259 Building Evidence for Effective and Sustainable Cigarette Warning Label Policy Univ. of South Carolina 05/01/2014 - 04/30/2015 07/01/2012 - 04/30/2015 R01CA167067/11590-FA59 (017180) $7,099 3,372 $10,471 Trans-Cranial Direct Current Stimulation to Treat Aphasia: Phase II Trial Univ. of South Carolina 04/01/2014 - 03/31/2015 04/01/2012 - 03/31/2017 U01DC011739/14-2655 (016746) $251,384 119,408 $370,792 02/01/2014 - 01/31/2015 02/10/2012 - 01/31/2017 $18,840 8,949 $27,789 Implementation of Prolonged Exposure in the Army: Is Consultation Necessary for Effective Dissemination? Univ. of Pennsylvania 10/01/2013 - 09/30/2014 07/01/2013 - 12/31/2014 W81XWH-12-2-0116/560165 (018236) $102,330 25,903 $128,233 TF-CBT for Adjudicated Youth in Residential Treatment Allegheny-Singer Research Inst. 12/01/2013 - 11/30/2014 07/15/2011 - 11/30/2014 R01MH095208/49243509MUSC (016597) $22,073 10,484 $32,557 Psychiatry & Behavioral Sciences Back, S (50% credit) Becker, H Brady, K Brady, K (50% credit) Cummings, K Cummings, K George, M Lopez, M Ruggiero, K Saunders, B Drug Abuse Research Training NIH/NIDA 5R25DA020537-09 (016674) Drug Abuse Research Training NIH/NIDA 5R25DA020537-09 (016674) Mouse Chronic Intermittent Ethanol (CIE) Core NIH/NIAAA 5U01AA020929-03 (016319) 11 May 2014 Medical University of South Carolina Printed: Jun 12, 2014 College of Medicine Psychiatry & Behavioral Sciences Sweat, M Phase II RCT of Comprehensive Triage HIV Prevention: Tanzania NIH/NIMH 05/01/2014 - 04/30/2015 07/19/2012 - 04/30/2015 5R01MH095869-03 (016905) $469,286 92,332 $561,618 Prolonging Remission in Depressed Elderly (PRIDE) Mt. Sinai School of Medicine 04/01/2014 - 03/31/2015 04/01/2014 - 03/31/2015 U01MH055495/0255-0106-4609 (018321) $230,764 114,228 $344,992 Surveillance of Spatial Case Event Data in Cancer Studies NIH/NCI 05/01/2014 - 04/30/2015 05/01/2014 - 04/30/2016 1R03CA179665-01A1 (018293) $50,000 23,079 $73,079 $5,119 2,432 $7,551 $400 100 $500 04/01/2014 - 12/30/2014 04/01/2014 - 12/30/2014 $28,000 0 $28,000 Evaluation of the GORE VIABAHN BALLOON EXPANDABLE ENDOPROSTHESIS (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries W.L. Gore and Associates, Inc. 04/29/2014 - 04/28/2019 04/29/2014 - 04/28/2019 BES 10-07 (018301) $41,392 11,518 $52,910 ENDOvascular Interventions with AngioMAX: The ENDOMAX Trial The Medicines Co. 04/29/2014 - 04/30/2015 04/29/2014 - 04/30/2015 MDCO-BIV-12-03 (018292) $55,931 16,029 $71,960 SC COBRE for Developmentally Based Cardiovascular Diseases NIH/NIGMS 05/01/2014 - 04/30/2015 08/01/2012 - 04/30/2017 5P30GM103342-03 (017096) $745,806 351,883 $1,097,689 Oxidative Stress and AICD in Memory T Cell Persistence NIH/NCI 05/01/2014 - 04/30/2015 06/02/2010 - 04/30/2015 5R01CA138930-05 (016662) $195,237 92,738 $287,975 Augmenting Anti-Tumor Immunity by Modulating IL-2/IL-15 Receptor Binding Melanoma Research Alliance 05/01/2014 - 04/30/2015 05/01/2013 - 04/30/2016 262885 (017693) $75,000 0 $75,000 Public Health Sciences Knapp, R Lawson, A Ramakrishnan, V Insights on Selected Procoagulation and Outcomes in Stroke Trial (I-SPOT) Temple University 02/01/2014 - 01/31/2015 02/01/2013 - 01/31/2018 5U01NS079077-02/361009-05430-02/PO173661 (017609) Radiology Guimaraes, M Schoepf, U Schonholz, C Schonholz, C GORE VIABAHN Endoprosthesis versus Percutaneous Transluminal Angioplasty (PTA) to Revise Arteriovenous Grafts at the Venous Anastomosi s in Hemodialysis Patients GORE REVISE Study W.L. Gore and Associates, Inc. 04/21/2014 - 06/30/2015 04/21/2014 - 06/30/2015 AVR 06-01 (018290) Siemens Fellowship Siemens Medical Solutions USA (018304) Regenerative Medicine & Cell Biology Markwald, R Surgery Mehrotra, S Rubinstein, M 12 May 2014 Medical University of South Carolina Printed: Jun 12, 2014 College of Medicine Urology Prasad, S Rovner, E A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis During Soft Tissue Open Surgeries PRA International 04/30/2014 - 12/31/2017 04/30/2014 - 12/31/2017 IG1103 (018299) $106,996 31,799 $138,795 A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS 400 mg in Women with Interstitial Cystitis Taris Biomedical, Inc. 05/08/2014 - 10/31/2016 05/08/2014 - 10/31/2016 TAR-100-202 (018310) $175,938 51,882 $227,820 13 May 2014
© Copyright 2024 ExpyDoc